While ATAI Life Sciences N.V. has overperformed by 2.07%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ATAI rose by 5.35%, with highs and lows ranging from $2.85 to $1.02, whereas the simple moving average jumped by 20.45% in the last 200 days.
On April 03, 2024, Maxim Group Upgraded ATAI Life Sciences N.V. (NASDAQ: ATAI) to Buy. A report published by Loop Capital on November 01, 2022, Initiated its previous ‘Buy’ rating for ATAI. Maxim Group also rated ATAI shares as ‘Buy’, setting a target price of $25 on the company’s shares in an initiating report dated November 30, 2021. ROTH Capital Initiated an Buy rating on November 11, 2021, and assigned a price target of $32. H.C. Wainwright initiated its ‘Buy’ rating for ATAI, as published in its report on October 18, 2021. Jefferies’s report from September 01, 2021 suggests a price prediction of $27 for ATAI shares, giving the stock a ‘Buy’ rating. RBC Capital Mkts also rated the stock as ‘Sector Perform’.
Analysis of ATAI Life Sciences N.V. (ATAI)
Further, the quarter-over-quarter decrease in sales is -52.63%, showing a negative trend in the upcoming months.
ATAI Life Sciences N.V.’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -15.97% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 9.22, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and ATAI has an average volume of 1.62M. On a monthly basis, the volatility of the stock is set at 10.76%, whereas on a weekly basis, it is put at 7.70%, with a gain of 5.35% over the past seven days. Furthermore, long-term investors anticipate a median target price of $9.50, showing growth from the present price of $1.97, which can serve as yet another indication of whether ATAI is worth investing in or should be passed over.
How Do You Analyze ATAI Life Sciences N.V. Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 30.44%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 8.24% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
ATAI shares are owned by institutional investors to the tune of 8.24% at present.
